Jason Napodano, CFA
Research analyst, medium-term horizon, biotech, small-cap

Tonix TNX-201 Ready For Clinical Development

On March 3, 2014 Tonix Pharmaceuticals (NASDAQ:TNXP) announced that they had recently held a pre-Investigational New Drug (pre-IND) meeting with the US. Food and Drug Administration (FDA) to discuss the development of TNX-201, a single isomer isometheptene (IMH) for the relief of episodic tension-type headache (ETTH).

Tension Type Headaches

Tension type headaches (TTH) are the most common type of headaches among adults and are also known as "stress headaches". These headaches were previously known by a number of terms, however the term "tension-type headache" was chosen by the International Classification Headache Diagnosis I (ICHD) in 1988 and later retained by ICHD II in 2004. The terms "tension" and "type" refer to the unknown nature of the

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details